Dr. Sara Hassan Beygi Monfared, MD

Dr. Monfared practices at Cleveland Clinic Akron General in Akron, Ohio, part of The Cleveland Clinic Foundation.

Dr. Monfared's NPI, 1699187948, was assigned on May 21, 2014. Dr. Monfared graduated from University of Missouri, Kansas City, School of Medicine in 2014. Dr. Monfared holds Ohio license 35.145849.

Dr. Monfared's primary practice is Cleveland Clinic Akron General, at 1 Akron General Avenue, Akron, OH 44307 in Summit County. The practice phone is (330) 344-6000.

Dr. Monfared's primary practice is Cleveland Clinic Akron General in Akron, Ohio, part of The Cleveland Clinic Foundation. Dr. Monfared is also affiliated with Cleveland Clinic Mercy Hospital. The medical group on file is Partners Physician Group. Dmand AI also links Dr. Monfared to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Monfared practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Monfared's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dmand AI has Dr. Monfared's licenses on file in 2 states: Ohio and Texas.

CMS data shows 31 Medicare services from Dr. Monfared across 2 procedure codes in 2024, for 49 Medicare patients. Medicare paid $1,451 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 49 Medicare patients who saw Dr. Monfared in 2024. The largest group is 65 to 74, with 19 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Monfared's median patient age at 49, with 73% women.

In 2024, Dr. Monfared wrote 130 Medicare Part D claims for 57 patients. 96% of them were for generic drugs. CMS names the drug for 93 of them, across 2 drugs with 11 or more claims each, at $3,065 in total drug cost. In 2023, CMS named 68 claims across 2 drugs.

Dr. Monfared accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 26 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Monfared, more than 54% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 21 papers to Dr. Monfared, published from 2019 to 2024. 2020 was the busiest year, with 7. The most frequent topics are Obesity, Morbid, Bariatric Surgery and Laparoscopy. Dr. Monfared has published most often in Surg Endosc. Dr. Monfared's most frequent co-authors are Dimitrios Stefanidis, MD, Ambar Banerjee, MD and Annabelle Rose Butler, MD.

CMS Open Payments shows 77 general payments to Dr. Monfared from 13 drug and device companies from 2018 to 2025. Education make up the largest share, 53% of the total. Intuitive Surgical, Inc. paid the most, $7,789.

Dr. Monfared graduated from University of Missouri, Kansas City, School of Medicine in 2014.